Reference SummaryDasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60
Title |
Maternal effects and cancer risk in the progeny of mice exposed to X-rays before conception. |
Authors |
Dasenbrock C; Tillmann T; Ernst H; Behnke W; Kellner R; Hagemann G; Kaever V; Kohler M; Rittinghausen S; Mohr U; Tomatis L |
Journal |
Exp Toxicol Pathol |
Volume |
56 |
Issue |
6 |
Year |
2005 |
Pages |
351-60 |
Abstract |
To investigate in an animal model whether preconceptual X-ray exposure leads to an altered tumor rate and spectrum in the offspring, a transgeneration carcinogenesis study was carried out. Female mice received X-ray irradiation (2 x 2 Gray) 2 weeks prior to mating with untreated males. After weaning, half of the descendants were exposed for 6 months to the immunomodulating and tumor-promoting compound cyclosporine A (CsA) by diet, the others remained untreated. The animals were maintained for their entire lifespan, terminal sacrifices were carried out after 28 months. Complete autopsy was performed, and three protocol organs (lung, liver and spleen) were examined histologically, together with any suspicious lesions in other organs. Fertility and the lifetime of the maternal mice were reduced by the X-ray irradiation, and their incidence of lung and liver tumors was increased as compared to non-irradiated mice. The descendants of all groups revealed comparable body weights and mortality rates. The incidence of hematopoietic/lymphoreticular tissue tumors increased in the female hybrids by 6 months of CsA-treatment. A higher incidence of lung and liver tumors in the sham-treated male progeny of irradiated mothers was detected, pointing to a possible germ cell-transmitted alteration initiated by the preconceptual maternal X-ray exposure. |
Links |
J:101100 – MGI References 15945274 – National Library of Medicine/PubMed |
Strain | Model Name | Treatment Agent(s) | Organ Affected | Frequency | Model Details |
---|---|---|---|---|---|
C57BL/6N | Blood vessel hemangioma | Liver |
1.4 |
||
C57BL/6N | Blood vessel hemangioma |
|
Liver |
0.4 |
|
(C57BL/6N x C3H/HeN)F1 | Blood vessel hemangioma | Liver |
0 - 1.9 |
||
(C57BL/6N x C3H/HeN)F1 | Blood vessel hemangioma |
|
Liver |
0 - 0.5 |
|
(C57BL/6N x C3H/HeN)F1 | Blood vessel hemangioma |
|
Liver |
0.5 - 1.0 |
|
(C57BL/6N x C3H/HeN)F1 | Blood vessel hemangioma |
|
Liver |
0.5 - 1.0 |
|
C57BL/6N | Blood vessel hemangiosarcoma | Liver |
1.4 |
||
C57BL/6N | Blood vessel hemangiosarcoma |
|
Liver |
0.4 |
|
(C57BL/6N x C3H/HeN)F1 | Blood vessel hemangiosarcoma | Liver |
2.3 - 7.0 |
||
(C57BL/6N x C3H/HeN)F1 | Blood vessel hemangiosarcoma |
|
Liver |
0.5 - 4.7 |
|
(C57BL/6N x C3H/HeN)F1 | Blood vessel hemangiosarcoma |
|
Liver |
1.0 - 6.2 |
|
(C57BL/6N x C3H/HeN)F1 | Blood vessel hemangiosarcoma |
|
Liver |
1.9 - 4.3 |
|
C57BL/6N | Blood vessel tumor | Liver |
2.7 |
||
C57BL/6N | Blood vessel tumor |
|
Liver |
0.9 |
|
(C57BL/6N x C3H/HeN)F1 | Blood vessel tumor | Liver |
3.8 - 7.0 |
||
(C57BL/6N x C3H/HeN)F1 | Blood vessel tumor |
|
Liver |
0.5 - 5.2 |
|
(C57BL/6N x C3H/HeN)F1 | Blood vessel tumor |
|
Liver |
1.9 - 6.7 |
|
(C57BL/6N x C3H/HeN)F1 | Blood vessel tumor |
|
Liver |
2.4 - 5.2 |
|
C57BL/6N | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Leukocyte - Monocyte - Macrophage - Histiocyte |
11.4 |
||
C57BL/6N | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma |
|
Leukocyte - Monocyte - Macrophage - Histiocyte |
8.3 |
|
(C57BL/6N x C3H/HeN)F1 | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Leukocyte - Monocyte - Macrophage - Histiocyte |
3.8 - 4.7 |
||
(C57BL/6N x C3H/HeN)F1 | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma |
|
Leukocyte - Monocyte - Macrophage - Histiocyte |
3.8 - 6.1 |
|
(C57BL/6N x C3H/HeN)F1 | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma |
|
Leukocyte - Monocyte - Macrophage - Histiocyte |
1.9 - 4.9 |
|
(C57BL/6N x C3H/HeN)F1 | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma |
|
Leukocyte - Monocyte - Macrophage - Histiocyte |
2.4 - 4.8 |
|
C57BL/6N | Leukocyte - Myelocyte (Granulocyte) leukemia - myelocytic | Leukocyte - Myelocyte (Granulocyte) |
1.4 |
||
C57BL/6N | Leukocyte - Myelocyte (Granulocyte) leukemia - myelocytic |
|
Leukocyte - Myelocyte (Granulocyte) |
1.3 |
|
(C57BL/6N x C3H/HeN)F1 | Leukocyte - Myelocyte (Granulocyte) leukemia - myelocytic | Leukocyte - Myelocyte (Granulocyte) |
0 |
||
(C57BL/6N x C3H/HeN)F1 | Leukocyte - Myelocyte (Granulocyte) leukemia - myelocytic |
|
Leukocyte - Myelocyte (Granulocyte) |
0 |
|
(C57BL/6N x C3H/HeN)F1 | Leukocyte - Myelocyte (Granulocyte) leukemia - myelocytic |
|
Leukocyte - Myelocyte (Granulocyte) |
0 |
|
(C57BL/6N x C3H/HeN)F1 | Leukocyte - Myelocyte (Granulocyte) leukemia - myelocytic |
|
Leukocyte - Myelocyte (Granulocyte) |
0.5 |
|
C57BL/6N | Leukocyte lymphoma | Leukocyte |
50.7 |
||
C57BL/6N | Leukocyte lymphoma |
|
Leukocyte |
59.1 |
|
(C57BL/6N x C3H/HeN)F1 | Leukocyte lymphoma | Leukocyte |
13.1 - 39.9 |
||
(C57BL/6N x C3H/HeN)F1 | Leukocyte lymphoma |
|
Leukocyte |
19.8 - 52.4 |
|
(C57BL/6N x C3H/HeN)F1 | Leukocyte lymphoma |
|
Leukocyte |
18.1 - 42.2 |
|
(C57BL/6N x C3H/HeN)F1 | Leukocyte lymphoma |
|
Leukocyte |
15.7 - 56.5 |
|
(C57BL/6N x C3H/HeN)F1 | Liver - Sinusoid - Ito cell tumor | Liver - Sinusoid - Ito cell |
0.9 - 1.4 |
||
(C57BL/6N x C3H/HeN)F1 | Liver - Sinusoid - Ito cell tumor |
|
Liver - Sinusoid - Ito cell |
0 |
|
(C57BL/6N x C3H/HeN)F1 | Liver - Sinusoid - Ito cell tumor |
|
Liver - Sinusoid - Ito cell |
0 - 1.9 |
|
(C57BL/6N x C3H/HeN)F1 | Liver - Sinusoid - Ito cell tumor |
|
Liver - Sinusoid - Ito cell |
0 |
|
(C57BL/6N x C3H/HeN)F1 | Liver hepatoblastoma | Liver |
0 |
||
(C57BL/6N x C3H/HeN)F1 | Liver hepatoblastoma |
|
Liver |
0 |
|
(C57BL/6N x C3H/HeN)F1 | Liver hepatoblastoma |
|
Liver |
0.5 |
|
(C57BL/6N x C3H/HeN)F1 | Liver hepatoblastoma |
|
Liver |
0 |
|
C57BL/6N | Liver hepatocellular adenoma | Liver |
2.7 |
||
C57BL/6N | Liver hepatocellular adenoma |
|
Liver |
3.9 |
|
(C57BL/6N x C3H/HeN)F1 | Liver hepatocellular adenoma | Liver |
6.1 - 14.6 |
||
(C57BL/6N x C3H/HeN)F1 | Liver hepatocellular adenoma |
|
Liver |
5.2 - 14.6 |
|
(C57BL/6N x C3H/HeN)F1 | Liver hepatocellular adenoma |
|
Liver |
2.4 - 16.7 |
|
(C57BL/6N x C3H/HeN)F1 | Liver hepatocellular adenoma |
|
Liver |
4.8 - 18.1 |
|
C57BL/6N | Liver hepatocellular carcinoma | Liver |
0.5 |
||
C57BL/6N | Liver hepatocellular carcinoma |
|
Liver |
3.9 |
|
(C57BL/6N x C3H/HeN)F1 | Liver hepatocellular carcinoma | Liver |
4.2 - 16.4 |
||
(C57BL/6N x C3H/HeN)F1 | Liver hepatocellular carcinoma |
|
Liver |
1.9 - 21.7 |
|
(C57BL/6N x C3H/HeN)F1 | Liver hepatocellular carcinoma |
|
Liver |
6.8 - 25.2 |
|
(C57BL/6N x C3H/HeN)F1 | Liver hepatocellular carcinoma |
|
Liver |
1.9 - 27.1 |
|
C57BL/6N | Liver hepatocellular tumor | Liver |
3.2 |
||
C57BL/6N | Liver hepatocellular tumor |
|
Liver |
7.8 |
|
(C57BL/6N x C3H/HeN)F1 | Liver hepatocellular tumor | Liver |
10.3 - 29.6 |
||
(C57BL/6N x C3H/HeN)F1 | Liver hepatocellular tumor |
|
Liver |
7.1 - 34.0 |
|
(C57BL/6N x C3H/HeN)F1 | Liver hepatocellular tumor |
|
Liver |
8.7 - 39.0 |
|
(C57BL/6N x C3H/HeN)F1 | Liver hepatocellular tumor |
|
Liver |
6.7 - 41.9 |
|
C57BL/6N | Lung adenoma | Lung |
2.3 |
||
C57BL/6N | Lung adenoma |
|
Lung |
7.0 |
|
(C57BL/6N x C3H/HeN)F1 | Lung adenoma | Lung |
6.6 - 12.7 |
||
(C57BL/6N x C3H/HeN)F1 | Lung adenoma |
|
Lung |
4.7 - 13.2 |
|
(C57BL/6N x C3H/HeN)F1 | Lung adenoma |
|
Lung |
3.9 - 21.0 |
|
(C57BL/6N x C3H/HeN)F1 | Lung adenoma |
|
Lung |
7.2 - 16.7 |
|
C57BL/6N | Lung carcinoma | Lung |
0.9 |
||
C57BL/6N | Lung carcinoma |
|
Lung |
3.9 |
|
(C57BL/6N x C3H/HeN)F1 | Lung carcinoma | Lung |
7.0 - 14.6 |
||
(C57BL/6N x C3H/HeN)F1 | Lung carcinoma |
|
Lung |
2.4 - 16.5 |
|
(C57BL/6N x C3H/HeN)F1 | Lung carcinoma |
|
Lung |
7.3 - 21.0 |
|
(C57BL/6N x C3H/HeN)F1 | Lung carcinoma |
|
Lung |
2.9 - 22.9 |
|
(C57BL/6N x C3H/HeN)F1 | Lung carcinoma - acinar | Lung |
0 - 0.5 |
||
(C57BL/6N x C3H/HeN)F1 | Lung carcinoma - acinar |
|
Lung |
0 |
|
(C57BL/6N x C3H/HeN)F1 | Lung carcinoma - acinar |
|
Lung |
0 - 0.5 |
|
(C57BL/6N x C3H/HeN)F1 | Lung carcinoma - acinar |
|
Lung |
0 - 0.5 |
|
C57BL/6N | Lung papilloma | Lung |
0 |
||
C57BL/6N | Lung papilloma |
|
Lung |
0.4 |
|
C57BL/6N | Lung tumor | Lung |
3.2 |
||
C57BL/6N | Lung tumor |
|
Lung |
10.9 |
|
(C57BL/6N x C3H/HeN)F1 | Lung tumor | Lung |
14.1 - 26.8 |
||
(C57BL/6N x C3H/HeN)F1 | Lung tumor |
|
Lung |
7.1 - 28.3 |
|
(C57BL/6N x C3H/HeN)F1 | Lung tumor |
|
Lung |
10.7 - 39.0 |
|
(C57BL/6N x C3H/HeN)F1 | Lung tumor |
|
Lung |
10.0 - 37.1 |
|
C57BL/6N | (Unspecified organ) tumor | (Unspecified organ) |
63.5 |
||
C57BL/6N | (Unspecified organ) tumor |
|
(Unspecified organ) |
68.7 |
|
(C57BL/6N x C3H/HeN)F1 | (Unspecified organ) tumor | (Unspecified organ) |
16.9 - 44.6 |
||
(C57BL/6N x C3H/HeN)F1 | (Unspecified organ) tumor |
|
(Unspecified organ) |
25.9 - 56.1 |
|
(C57BL/6N x C3H/HeN)F1 | (Unspecified organ) tumor |
|
(Unspecified organ) |
20.0 - 47.1 |
|
(C57BL/6N x C3H/HeN)F1 | (Unspecified organ) tumor |
|
(Unspecified organ) |
20.5 - 59.3 |